Eight Years of ADCETRIS (R) in Hodgkin Lymphoma Therapy: Chance of Healing in all Therapy Lines

首页> 外文期刊>Oncology research and treatment. >Eight Years of ADCETRIS (R) in Hodgkin Lymphoma Therapy: Chance of Healing in all Therapy Lines

【24h】

Eight Years of ADCETRIS (R) in Hodgkin Lymphoma Therapy: Chance of Healing in all Therapy Lines

机译：八年的Adcetris（R）在霍奇金淋巴瘤治疗：所有治疗线中愈合的机会

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Oncology research and treatment.》 |2021年第5期|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
入库时间 2022-08-20 18:45:41

相似文献

外文文献
中文文献
专利

1. Hepatitis C Associated B-cell Non-Hodgkin Lymphoma:Clinical Features and the Role of Antiviral Therapy [J] . Syed Tasleem, Gagan K Sood 临床与转化肝病杂志（英文版） . 2015,第002期
2. Hodgkin Lymphoma Transformation of Chronic Lymphocytic Leukemia Under Ibrutinib Therapy: Chance Association or Therapy-related? [J] . Sachanas Sotirios, Pangalis Gerassimos A., Moschogiannis Maria, Anticancer Research: International Journal of Cancer Research and Treatment . 2017,第6期

机译：岩豆淋巴细胞白血病在伊布勒替尼治疗下的转化：机会协会或治疗相关？
3. Relapsed and refractory Hodgkin- Lymphoma Chances of Healing with Brentuximab Vedotin: 5-Year- Survival Rates show persistent Remissions [J] . Schmale Ine Oncology research and treatment. . 2016,第1a2期

机译：布伦妥昔单抗Vedotin治疗复发性和难治性霍奇金淋巴瘤的机会：5年生存率显示持续缓解
4. Proton Therapy for Management of Pediatric Hodgkin Lymphoma Involving the Mediastinum: Evaluation of Toxicity and Evolution of Therapy Over 7 Years of Experience [J] . Arscott W. T., Cope C., Kersun L., International Journal of Radiation Oncology, Biology, Physics . 2018,第3Suppla期

机译：Proton疗法治疗涉及纵隔的儿科霍奇金淋巴瘤：7年经验毒性评估和治疗的演变
5. Unusual Presentations of Central Nervous System Non-Hodgkin and Hodgkin Lymphoma: A Clinicopathologic Review of Four Tumours [C] . Lee HY, Chuah KL, Ng SB, International Congress of Neuropathology . 2010

机译：中枢神经系统非霍奇金和霍格金淋巴瘤的不寻常介绍：对四种肿瘤的临床病理综述
6. TP73 in Non-Hodgkin lymphoma pathogenesis and therapy. [D] . Hassan, Hesham M. 2014

机译：TP73在非霍奇金淋巴瘤的发病机理和治疗中。
7. Dose-Modified Ifosfamide Epirubicin and Etoposide is a Safe and EffectiveSalvage Therapy with High Peripheral Blood Stem Cell Mobilization Capacity for PoorlyMobilized Hodgkin’s Lymphoma and Non-Hodgkin’s Lymphoma Patients [O] . Akiko Fukunaga, Mizuki Hyuga, Makoto Iwasaki, 2016

机译：剂量修饰的异环磷酰胺表柔比星和依托泊苷是安全有效的高外周血干细胞动员能力的抢救疗法动员霍奇金淋巴瘤和非霍奇金淋巴瘤患者
8. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large cell B-Cell Non-Hodgkin’s lymphoma1,2 1Expert panel members and authors of the review are: Theresa Hahn, PhD, Roswell Park Cancer Institute, Buffalo, NY; Steven N. Wolff, MD, Vanderbilt University, Nashville, TN, Myron Czuczman, MD, Roswell Park Cancer Institute, Buffalo, NY; Richard I. Fisher, MD, Cardinal Bernardin Cancer Center, Loyola University, Chicago, IL; Hillard M. Lazarus, MD, Comprehensive Cancer Center, University Hospitals of Cleveland, Case Western Reserve University, Cleveland, OH; Philip L. McCarthy, MD, Roswell Park Cancer Institute, Buffalo, NY; Julie Vose, MD, University of Nebraska Medical Center, Omaha, NE; Lisa Warren, Cure for Lymphoma Foundation, New York, NY; and Richard Watt, MD, United Resource Networks, Minneapolis, MN. 2Reference: Hahn T, Wolff SN, Czuczman M, et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin’s lymphoma: an evidence-based review. Biol Blood Marrow Transplant. 2001;7:308–331. [O] . 2003

机译：造血干细胞移植的细胞毒性治疗在治疗弥漫性大细胞B细胞非霍奇金淋巴瘤1,2中的作用1，专家小组成员和评价的作者是：纽约州布法罗罗斯威尔公园癌症研究所的特蕾莎·哈恩博士；田纳西州纳什维尔范德比尔特大学医学博士斯蒂芬·沃尔夫（Steven N. Wolff），纽约州布法罗罗斯维尔公园癌症研究所医学博士迈伦·库兹曼（Myron Czuczman）；理查德·费舍尔（Richard I. Fisher）医学博士，伊利诺伊州芝加哥洛约拉大学贝纳尔丁枢机主教癌症中心；俄亥俄州克利夫兰凯斯西储大学克利夫兰大学医院综合癌症中心医学博士Hillard M. Lazarus；纽约州布法罗罗斯韦尔公园癌症研究所医学博士Philip L.内布拉斯加州奥马哈市内布拉斯加大学医学中心医学博士Julie Vose；丽莎·沃伦（Lisa Warren），纽约州纽约市淋巴瘤基金会的治疗；和明尼苏达州明尼阿波利斯市联合资源网络公司的医学博士Richard Watt。 2参考文献：Hahn T，Wolff SN，Czuczman M等。一项基于证据的综述：造血干细胞移植的细胞毒性治疗在弥漫性大细胞B细胞非霍奇金淋巴瘤治疗中的作用。 Biol骨髓移植。 2001; 7：308-331。
9. Osteoimmune Mechanisms of Segmental Bone Fracture Healing and Therapy. [R] . Ponnazhagan, S. 2016

机译：骨折骨折愈合和治疗的骨质疏松机制。

Eight Years of ADCETRIS (R) in Hodgkin Lymphoma Therapy: Chance of Healing in all Therapy Lines

著录项

相似文献

相关主题

期刊订阅